[Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
Grigor'ev
P Ia
PIa
Isakov
V A
VA
Vasil'eva
Z I
ZI
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D010890:Pirenzepine / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D009942:Organometallic Compounds; D010890:Pirenzepine; C002791:bismuth tripotassium dicitrate; D009853:Omeprazole
Patofiziologicheskie osnovy farmakoterapii iazvennoĭ bolezni.